Products

Primary tabs

Export products to Excel

Displaying 91 - 105 of 109
Alternative Name: NSP-989; NSP-989 COMBO; Tanaproget COMBO; WAY-166989
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Oral
Project Stage: Phase II
Alternative Name: Tenofovir Disoproxil Fumarate (TDF) +Levonorgestrel Vaginal Ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase I
Alternative Name: TV-46046
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Phase I
Alternative Name: Tenofovir (TFV) and levonorgestrel (LNG) ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase I
Partner: CONRAD
Alternative Name: Clean Sheets Pill, Inhibition of Vas Propulsive Contractility
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Project Stage: Pre-clinical
Alternative Name: Tubal Occlusion via Ultrasound
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Pre-clinical
Partner: FHI 360
Alternative Name: LNG Contraceptive IUS 12 (LCS12)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Regulatory
Partner: Bayer HealthCare
Alternative Name: Ulipristal acetate (UPA) Intrauterine System (IUS)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Pre-clinical
Alternative Name: Ulipristal acetate (UPA) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Alternative Name: S-003296
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Pre-clinical
Alternative Name: Vas deferens polymer contraceptive
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Vas Deferens
Project Stage: Pre-clinical
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Phase II
Partner: ContraMed, LLC
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Partner: DAIDS, Merck, NIAID
Alternative Name: WEE1 HOMOLOG 2, WEE1B, WEE2 Kinase
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Lead Optimization
Export to Excel